Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)
Background:
The brain enzyme phosphodiesterase-4D (PDE4D) may affect thinking and depression. Drugs with some radioactivity can attach to enzymes and be seen on a scan. Researchers want to test a new radioactive drug, 11C-T-1650, to measure PDE4D in the brain and body. They also want to see if the new drug BPN14770 blocks 11C-T-1650 from the brain. They want to learn more about psychiatric disorders and possible treatments.
Objectives:
To study how well 11C-T-1650 helps show PDE4D on a scan and to see if BPN14770 blocks it.
Eligibility:
Healthy adults at least 18 years old
Design:
Participants will be screened in other protocols.
Some participants will have 1 body PET scan.
Some participants will have 2 brain PET scans and 1 brain MRI within 1 year.
Some participants (ages 18 55) will:
Have 3 brain PET scans and 1 MRI
Take BPN14770 by mouth twice daily for 3 7 days
Have blood and urine tests
Have a follow-up physical exam and heart test
PET (positron emission tomography) scans will take 2 3 hours. Participants will:
Have a thin plastic tube (catheter) placed in an arm vein by needle.
Get a small amount of 11C-T-1650 injected via catheter. Another catheter may be placed to draw blood.
Lie quietly on a bed that slides into a donut-shaped scanner without sleeping. They may get a short break.
Have heart and vital signs monitored.
Have blood and urine tests.
Learn about drinking fluids and urinating after the scan
MRI (magnetic resonance imagining) scans will take 30 60 minutes:
Participants will lie on a table that slides into a metal cylinder in a magnetic field.
Sponsoring Institute: National Institute of Mental Health
...
100 项与 11C-T-1650 相关的临床结果
100 项与 11C-T-1650 相关的转化医学
100 项与 11C-T-1650 相关的专利(医药)
100 项与 11C-T-1650 相关的药物交易